查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596681

脊椎生技藥品市場：按產品、應用和最終用戶分類 - 全球預測 2025-2030

Spine Biologics Market by Product (Bone Graft Substitutes, Cell-Base Matrix, Spinal Allografts), Application (Non-Fusion, Spinal Fusion), End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年脊椎生技藥品市場規模預估為30億美元，預估2024年將達31.5億美元，複合年成長率為5.24%，預估2030年將達43億美元。

脊椎生技藥品市場是更廣泛的醫用生物材料和生物療法領域中的一個專門領域，主要關注促進脊椎癒合和再生的產品。這通常包括移植骨替代物、生長因子和脊椎融合手術中使用的基於細胞的基質。脊椎生技藥品的需求源於脊椎疾病的日益流行，例如退化性椎間盤疾病、脊椎狹窄和創傷性脊椎損傷，這些疾病由於人口老化和久坐的生活方式而變得更加普遍。脊椎融合手術旨在透過促進骨骼生長來穩定脊椎，並緩解慢性背痛和不穩定性。最終用途領域包括醫院、專科診所和門診手術中心，微創手術的趨勢日益成長，以加速患者康復並降低手術風險。

主要市場統計
基準年[2023] 30億美元
預測年份 [2024] 31.5億美元
預測年份 [2030] 43億美元
複合年成長率（%） 5.24%

影響市場的關鍵成長要素包括生技藥品的技術進步、患者對微創手術的偏好增加以及再生療法的廣泛研究和開發活動。最新的機會存在於新興市場，這些市場的醫療基礎設施不斷擴大，人們對先進治療的認知不斷增強。此外，生物技術公司和醫院之間的夥伴關係可以在加速創新脊椎生技藥品解決方案的採用方面發揮作用。然而，市場開拓受到高昂的開發成本、嚴格的監管核准以及某些地區的報銷挑戰的限制，從而阻礙了產品的可用性。

具有技術創新潛力的領域包括開發提供更大完整性和縮短癒合時間的新生物材料，以及探索基因療法和組織工程以創建可自訂的治療方法。探索個人化醫療方法也可能提供競爭優勢。隨著技術的快速進步，市場相對活躍，因此保持領先於不斷變化的臨床需求和監管環境至關重要。能夠有效平衡技術創新與可負擔性和監管合規性的公司將能夠實現持續成長並提高脊椎生技藥品領域的市場滲透率。

市場動態：揭示快速發展的生技藥品市場的關鍵市場洞察

供需的動態交互作用正在改變脊椎生技藥品市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 對微創手術的需求和偏好不斷成長
    • 退化性脊椎疾病的盛行率和治療率不斷增加
    • 骨移植技術的快速進步
  • 市場限制因素
    • 治療費用上漲
  • 市場機會
    • 生物材料的持續進步改善脊椎疾病的治療
    • 政府資助擴大研究
  • 市場問題
    • 產品召回問題

波特的五力：駕馭脊椎生技藥品市場的策略工具

波特的五力架構是了解脊椎生技藥品市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解脊椎生技藥品市場的外部影響

外部宏觀環境因素在塑造脊椎生技藥品市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解脊椎生技藥品市場的競爭格局

對脊椎生技藥品市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：脊椎生技藥品市場供應商的績效評估

FPNV 定位矩陣是評估脊椎生技藥品市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製脊椎生技藥品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對脊椎生技藥品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率：對當前市場環境的詳細審查，主要企業的廣泛資料，評估他們在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對微創手術的需求和偏好不斷成長
      • 退化性脊椎疾病的發生率和治療率不斷增加
      • 骨移植手術的快速進展
    • 抑制因素
      • 治療費用高
    • 機會
      • 生物材料的持續進步改善脊椎疾病的治療
      • 擴大政府資助的脊椎生技藥品研究
    • 任務
      • 產品召回問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章脊椎生技藥品市場：依產品

  • 介紹
  • 骨移植替代品
    • 骨形成蛋白
    • 人工骨移植
  • 基於細胞的矩陣
  • 同種異體脊椎移植物
    • 去礦骨基質
    • 機械加工同種異體骨

第7章脊椎生技藥品市場：依應用分類

  • 介紹
  • 不融合
  • 脊椎融合手術

第8章脊椎生技藥品市場：依最終用戶分類

  • 介紹
  • 門診手術中心
  • 醫院

第9章美洲脊椎生技藥品市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太脊椎生技藥品市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲脊椎生技藥品市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Bone Biologics 獲得人體研究倫理委員會核准，開始在澳洲脊椎融合手術患者中進行 NB1 試驗臨床試驗
    • PUR Biologics 宣布推出 PURcore，一種用於脊椎手術的生物活性可塑合成材料
    • Induce Biologics 宣布推出 NMP 鬆質條
  • 戰略分析和建議

公司名單

  • Alphatec Spine, Inc.
  • Arthrex Inc.
  • Aziyo Biologics
  • Baxter International Inc.
  • Biomatlante SAS
  • Bone Biologics Corp.
  • Camber Spine Technologies, LLC
  • Cerapedics, Inc
  • ChoiceSpine LLC
  • CoreLink, LLC by ZAVATION
  • Globus Medical, Inc.
  • Induce Biologics USA Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Corporation
  • InVivo Therapeutics Corp.
  • Johnson & Johnson Services, Inc.
  • Kuros Biosciences AG
  • Life Spine, Inc.
  • LifeNet Health
  • Medtronic PLC
  • MTF Biologics
  • ORHub Inc
  • Orthofix Medical Inc.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Spinal Elements, Inc.
  • Stryker Corporation
  • Tyber Medical LLC
  • Xtant Medical Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-A86604082622

The Spine Biologics Market was valued at USD 3.00 billion in 2023, expected to reach USD 3.15 billion in 2024, and is projected to grow at a CAGR of 5.24%, to USD 4.30 billion by 2030.

The spine biologics market is a specialized sector within the broader field of medical biomaterials and biological therapies, primarily focused on products that promote spinal healing and regeneration. This typically includes bone graft substitutes, growth factors, and cell-based matrices used in spinal fusion procedures. The necessity of spine biologics arises from the increasing prevalence of spinal disorders such as degenerative disc disease, spinal stenosis, and traumatic spinal injuries, which are often exacerbated by aging populations and sedentary lifestyles. Applications extend predominantly to spinal fusion surgeries, which aim to alleviate chronic back pain and instability by enhancing bone growth and thus stabilizing the spinal column. End-use segments include hospitals, specialty clinics, and ambulatory surgical centers, with an increasing trend toward minimally invasive procedures that accelerate patient recovery and reduce surgical risks.

KEY MARKET STATISTICS
Base Year [2023] USD 3.00 billion
Estimated Year [2024] USD 3.15 billion
Forecast Year [2030] USD 4.30 billion
CAGR (%) 5.24%

Key growth factors influencing the market include technological advancements in biologics, increasing patient preference for minimally invasive surgeries, and extensive R&D activities in regenerative therapies. The latest opportunities lie in emerging markets with expanding healthcare infrastructures and increasing awareness of advanced treatments. Furthermore, partnerships between biotech firms and hospitals could serve to expedite the adoption of innovative spine biologics solutions. However, market growth is constrained by high costs of development, stringent regulatory approvals, and reimbursement challenges in certain regions, which can hinder product accessibility.

Potential areas for innovation include the development of new biologic materials that offer better integration and healing time, and the exploration of gene therapy and tissue engineering to create customizable therapies. Research into personalized medicine approaches can also provide a competitive edge. As the market is relatively dynamic with rapid technological progress, it is crucial to stay ahead of evolving clinical demands and regulatory landscapes. Firms that can effectively balance innovation with affordability and regulatory compliance are likely to see sustained growth and increased market penetration in the spine biologics arena.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Spine Biologics Market

The Spine Biologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand and preference for minimally invasive procedures
    • Rising incidence of degenerative spine disorders and rise in treatment rates
    • Proliferation in advancements of bone grafting procedures
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Ongoing advancements in biomaterials improving the treatment of spine disorders
    • Government funding to expand spine biologics research
  • Market Challenges
    • Issues related to product recalls

Porter's Five Forces: A Strategic Tool for Navigating the Spine Biologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Spine Biologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Spine Biologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Spine Biologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Spine Biologics Market

A detailed market share analysis in the Spine Biologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Spine Biologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Spine Biologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Spine Biologics Market

A strategic analysis of the Spine Biologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spine Biologics Market, highlighting leading vendors and their innovative profiles. These include Alphatec Spine, Inc., Arthrex Inc., Aziyo Biologics, Baxter International Inc., Biomatlante SAS, Bone Biologics Corp., Camber Spine Technologies, LLC, Cerapedics, Inc, ChoiceSpine LLC, CoreLink, LLC by ZAVATION, Globus Medical, Inc., Induce Biologics USA Inc., Innovasis, Inc., Integra LifeSciences Corporation, InVivo Therapeutics Corp., Johnson & Johnson Services, Inc., Kuros Biosciences A.G., Life Spine, Inc., LifeNet Health, Medtronic PLC, MTF Biologics, ORHub Inc, Orthofix Medical Inc., RTI Surgical, Inc., Smith & Nephew PLC, Spinal Elements, Inc., Stryker Corporation, Tyber Medical LLC, Xtant Medical Holdings, Inc., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Spine Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bone Graft Substitutes, Cell-Base Matrix, and Spinal Allografts. The Bone Graft Substitutes is further studied across Bone Morphogenetic Proteins and Synthetic Bone Grafts. The Spinal Allografts is further studied across Demineralized Bone Matrix and Machined Bones Allograft.
  • Based on Application, market is studied across Non-Fusion and Spinal Fusion.
  • Based on End-user, market is studied across Ambulatory Surgical Centers and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand and preference for minimally invasive procedures
      • 5.1.1.2. Rising incidence of degenerative spine disorders and rise in treatment rates
      • 5.1.1.3. Proliferation in advancements of bone grafting procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in biomaterials improving the treatment of spine disorders
      • 5.1.3.2. Government funding to expand spine biologics research
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to product recalls
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Spine Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Bone Graft Substitutes
    • 6.2.1. Bone Morphogenetic Proteins
    • 6.2.2. Synthetic Bone Grafts
  • 6.3. Cell-Base Matrix
  • 6.4. Spinal Allografts
    • 6.4.1. Demineralized Bone Matrix
    • 6.4.2. Machined Bones Allograft

7. Spine Biologics Market, by Application

  • 7.1. Introduction
  • 7.2. Non-Fusion
  • 7.3. Spinal Fusion

8. Spine Biologics Market, by End-user

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals

9. Americas Spine Biologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Spine Biologics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Spine Biologics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
    • 12.3.2. PUR Biologics Announces Launch of PURcore, a bioActive Moldable Synthetic for Spine Surgery
    • 12.3.3. Induce Biologics Announces Launch of NMP Cancellous Strips
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alphatec Spine, Inc.
  • 2. Arthrex Inc.
  • 3. Aziyo Biologics
  • 4. Baxter International Inc.
  • 5. Biomatlante SAS
  • 6. Bone Biologics Corp.
  • 7. Camber Spine Technologies, LLC
  • 8. Cerapedics, Inc
  • 9. ChoiceSpine LLC
  • 10. CoreLink, LLC by ZAVATION
  • 11. Globus Medical, Inc.
  • 12. Induce Biologics USA Inc.
  • 13. Innovasis, Inc.
  • 14. Integra LifeSciences Corporation
  • 15. InVivo Therapeutics Corp.
  • 16. Johnson & Johnson Services, Inc.
  • 17. Kuros Biosciences A.G.
  • 18. Life Spine, Inc.
  • 19. LifeNet Health
  • 20. Medtronic PLC
  • 21. MTF Biologics
  • 22. ORHub Inc
  • 23. Orthofix Medical Inc.
  • 24. RTI Surgical, Inc.
  • 25. Smith & Nephew PLC
  • 26. Spinal Elements, Inc.
  • 27. Stryker Corporation
  • 28. Tyber Medical LLC
  • 29. Xtant Medical Holdings, Inc.
  • 30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. SPINE BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. SPINE BIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPINE BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPINE BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SPINE BIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY CELL-BASE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY DEMINERALIZED BONE MATRIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY MACHINED BONES ALLOGRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY NON-FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SPINE BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES SPINE BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SPINE BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY SPINAL ALLOGRAFTS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM SPINE BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. SPINE BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. SPINE BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023